[Clinical analysis of ovarian metastasis in patients with Ⅰb stage cervical adenocarcinoma]

Zhonghua Yi Xue Za Zhi. 2016 Jan 19;96(3):203-6. doi: 10.3760/cma.j.issn.0376-2491.2016.03.011.
[Article in Chinese]

Abstract

Objective: To investigate the rate of ovarian metastasis and its related factors in patients with cervical adenocarcinoma, and explore whether the ovary should be reserved or not in cervical adenocarcinoma.

Method: The clinical data of 111 patients with cervical adenocarcinoma who received extensive total hysterectomy plus pelvic lymph node resection in Sun Yat-sen Memorial Hospital and Quanzhou Women's and Children's Hospital from January 2008 to December 2014 were collected and analyzed by single factor χ(2) test and multivariate logistic regression analysis.

Results: The median age of the included 111 cases of cervical adenocarcinoma was 44. Sixty-five of the patients were stage Ⅰb1, while 46 were stage Ⅰb2. The single factor analysis indicated that lymph-vascular space invasion(LSVI), lymph node status, interstitial infiltration depth, parametrial involvement and involvement of cervical body junction were associated with ovarian metastasis. Multivariate analysis indicated that LSVI (HR: 47.01, 95% CI: 2.48-890.03, P=0.010) and lymph node status (HR: 23.58, 95% CI: 1.20-463.21, P=0.038) were independent risk factors for ovarian metastasis.

Conclusions: Ovarian metastasis rate of stage Ⅰb cervical adenocarcinoma is low; patients with age less than or equal to 45 years old, negative LSVI, <1/2 cervical stromal invasion, no lymph node metastasis and no cervical body junction involvement can consider preservation of ovary; but these findings still need to be further confirmed by large randomized controlled trials.

MeSH terms

  • Adenocarcinoma / secondary*
  • Female
  • Humans
  • Hysterectomy
  • Lymph Node Excision
  • Lymph Nodes
  • Lymphatic Metastasis
  • Multivariate Analysis
  • Neoplasm Staging
  • Ovarian Neoplasms*
  • Pelvis
  • Retrospective Studies
  • Risk Factors
  • Uterine Cervical Neoplasms*